← Eichor
Condition: Von Willebrand Disease Vwd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Von Willebrand Disease Vwd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06090201The Severe Von Willebrand Disease (sVWD) Patient Registry
Phase N/A · 1 location(s) · VWD Connect Foundation · NCT05437536Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07358013Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Phase 1/Phase 2 · 25 location(s) · Vega Therapeutics, Inc · NCT05776069A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Phase N/A · 17 location(s) · Hemab ApS · NCT06610201An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)
Phase N/A · 1 location(s) · Takeda · NCT07404644Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
Phase 2 · 1 location(s) · Medical University of Vienna · NCT07273721Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
NA · 17 location(s) · University Hospital, Lille · NCT06651255Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Phase 3 · 14 location(s) · Vega Therapeutics, Inc · NCT07115004A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Phase 3 · 21 location(s) · Takeda · NCT05582993A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
Phase 3 · 7 location(s) · Takeda · NCT07129343A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
Phase 3 · 1 location(s) · Unity Health Toronto · NCT06205095A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · 25 location(s) · Hemab ApS · NCT06754852Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Phase 1 · 12 location(s) · Bleeding and Clotting Disorders Institute Peoria, Illinois · NCT05500807A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von
Phase 2 · 9 location(s) · Shanghai RAAS Blood Products Co., Ltd. · NCT07640893
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.